UBI Pharma Inc.   Report issue

For profit Phase 3
Founded: Zhubei City Taiwan (2014)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2016
NCT02708914
First Marketed Drug
2020
desmopressin (ddavp)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

UBI | UBITECH